Prevalence of diabetic retinopathy and distal symmetrical diabetic polyneuropathy, and glomerular filtration screening upon the diagnosis of type 2 diabetes mellitus – a cohort study

Česká verzia

Authors: L. Buková ¹; P. Galajda ²; M. Mokáň ²
Authors place of work: Diabetologická ambulancia II. internej kliniky SZÚ a FNsP F. D. Roosevelta Banská Bystrica, Slovenská republika, prednosta MU Dr. Ľubomír Skladaný, PhD., h. doc. ¹; I. interná klinika Jesseniovej lekárskej fakulty UK a UN Martin, Slovenská republika, prednosta prof. MU Dr. Marián Mokáň, DrSc., FRCP Edin ²
Published in the journal: Vnitř Lék 2013; 59(11): 955-960
Category: Original Contributions

Summary

The prospective cohort study analyzes the prevalence of microvascular complications at the time of diagnosis type 2 diabetes (DM 2). We were monitoring 200 outpatients (117 men and 83 women, aged from 30 to 92 years) with newly diagnosed and previously untreated type 2 diabetes mellitus during the period of August 2007 – August 2011 accidentally sending GP or internists. Prevalence of diabetic retinopathy in men was 0.85% and in women 1.2%. The prevalence of diabetic distal symetric polyneuropathy in men was 53% and in women 62%. The median of glomerular filtration based on a simplified MDRD‑ 4 equation (according to the study Modification of Diet in Renal Disease) was 1.27 ± 0.6 ml/ s/ 1.73 m² for men and 1.05 ± 0.32 ml/ s/ 1.73 m² for women. At baseline, 16.6% of men and 46.2% of women enrolled in our cohort study had glomerular filtration rate < 1 ml/ s/ 1.73 m².

Key words:
newly diagnosed type 2 diabetes mellitus – diabetic retinopathy – diabetic neuropathy – glomerular filtration rate

Zdroje

1. Buková L, Galajda P, Mokáň M. The prevalence of coronary heart disease, stroke and selected co‑ morbidities in patients with newly diagnosed type 2 diabetes – population‑based cohort study of outpatients. Acta Medica Martiniana 2013; 13: 33– 43.

2. Mancia G, De Backer G, Dominiczak L et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESH). Eur Heart J 2007; 28: 1462– 1536.

3. Okša A, Ponťuch P, Spustová V et al. Diabetická nefropatia – diagnostika, prevencia a liečba: odporúčané postupy Slovenskej nefrologickej spoločnosti a Slovenskej diabetologickej spoločnosti. Diabetes a obezita 2012; 24: 99– 107.

4. de Fine Olivarius N, Nielsen NV, Andreasen AH. Diabetic retinopathy in newly diagnosed middle–aged and elderly diabetic patients: prevalence and interrelationship with microalbuminuria and triglycerides. Graefes Arch Clin Exp Ophthalmol 2001; 239: 664– 672.

5. Tapp RJ, Shaw JE, Harper CA et al. AusDiab Study Group: The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003; 26: 1731– 1737.

6. Rema M, Deepa R, Mohan V. Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in south India. Br J Ophthalmol 2000; 84: 1058– 1060.

7. Talu S, Kaucsar E, Soreanu A. Diabetic retinopathy in newly diagnosed patients with type II diabetes mellitus (in Romanian). Oftalmologia 2002; 54: 27– 30.

8. Homoud Al‑ Zuabi, Yaqoub Al‑ Tammar, Reem Al‑ Moataz et al. Retinopathy in newly diagnosed type 2 diabetes mellitus. Med Princ Pract 2005; 14: 293– 296.

9. Dyck PJ. Diabetic polyneuropathies, retinopathy and nefropathy increased in newly diagnosed diabetes. Diab Care 2012; 35: 584– 591.

10. Krahulec B. Diabetická neuropatia. In: Mokáň M, Martinka E, Galajda P et al (eds). Diabetes mellitus a vybrané metabolické ochorenia. Martin: Vydavateľstvo P + M 2008: 588– 607.

11. Tesfaye S, Chaturvedi N, Eaton SE et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341– 350.

12. Praddepa R, Rema M, Vignesh J et al. Prevalence and risk factors for diabetic neuropathy in a urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURRES‑ 55). Diabet Med 2008; 4: 407– 412.

13. Bruce SG, Young TK. Prevalence and Risk Factors for Neuropathy in a Canadians First Nation Community. Diab Care 2008; 9: 1837– 1841.

14. Morkeid K, Ali L, Hussain. A Risk factors and prevalence of diabetic peripheral neuropathy. A study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries 2010; 1: 11– 17.

15. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation Community. Diab Care 2008; 9: 1837– 1841.

16. Dutta A, Naorem S, Singh TP et al. Prevalence of peripheral neuropathy in newly diagnosed type 2. diabetes. Int J Diabetes Dev Ctries 2002; 25: 30– 33.

17. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Indian J Med Res 2012; 136: 46– 53.

18. Alwakeel JS, Isnani AC, Alsuwaida A et al. Factors affecting the progression of diabetic nephropathy and its complications. A single‑center experience in Saudi Arabia. Ann Saudi Med 2011; 3: 236– 242.

19. Fong DS, Aiello LP, Ferris FL. Diabetic retinopathy. Diab Care 2004; 27: 2540– 2553.

20. Kalvodová B. Screening diabetické retinopatie. In: Rozsíval P et al (eds). Trendy soudobé oftalmologie, svazek 3. Praha: Galén 2006.

21. Kalvodová B. Diabetická retinopatie – komentář. Med Prom 2004; 5: 31– 34.

22. Beszédešová N. Screening diabetickej retinopatie. Interní Med 2007; 9: 345– 348.

23. Dia život. Dostupné z: http:/ / www.diazivot.hcz/ data/ standardy/ 2– nefropatie.pdf.

24. Pafčugová J, Kvapil M. Klinický význam vyšetření mikroalbuminurie. In: Kvapil M et al (eds). Diabetologie 2012. Praha: Triton 2012: 209– 217.

25. Ponťuch P. Diabetická nefropatia. In: Mokáň M, Martinka E, Galajda P et al (eds). Diabetes mellitus a vybrané metabolické ochorenia. Martin: Vydavateľstvo P + M 2008: 552– 564.

26. Dzúrik R, Spustová V. Vyšetrenia chorôb obličiek. In: Dzúrik R et al (eds). Štandardná klinickobiochemická diagnostika. Martin: Osveta 1996: 375– 380.

27. Ponťuch P, Lištiaková D, Černá K et al. Výskyt mikroalbuminúrie, klinickej proteinúrie a artériovej hypertenzie u diabetikov 2. typu na Slovensku. Diabetes a obezita 2004; 4: 41– 48.